Lenalidomide-acetylene-Br is a PROTAC Linker taht makes up HJM-561 ( HY-156698 ). HJM-561 is a potent, selective, and orally active EGFR PROTAC to inhiibit Osimertinib ( HY-15772 )-resistant EGFR triple mutations.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > PROTAC | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Signaling Pathways > PROTAC Linkers
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。